These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 25117446)

  • 21. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
    Divya CS; Pillai MR
    Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
    Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
    Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression.
    Zheng J; Deng YP; Lin C; Fu M; Xiao PG; Wu M
    Int J Cancer; 1999 Jul; 82(2):286-92. PubMed ID: 10389765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide.
    He G; Wang Q; Zhou Y; Wu X; Wang L; Duru N; Kong X; Zhang P; Wan B; Sui L; Guo Q; Li JJ; Yu L
    Int J Gynecol Cancer; 2011 Aug; 21(6):1097-104. PubMed ID: 21792014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteolin induces intrinsic apoptosis via inhibition of E6/E7 oncogenes and activation of extrinsic and intrinsic signaling pathways in HPV-18-associated cells.
    Ham S; Kim KH; Kwon TH; Bak Y; Lee DH; Song YS; Park SH; Park YS; Kim MS; Kang JW; Hong JT; Yoon DY
    Oncol Rep; 2014 Jun; 31(6):2683-91. PubMed ID: 24789165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of p53-dependent apoptosis signal in antitumor effect of Colchicine on human papilloma virus (HPV)-positive human cervical cancer cells.
    Yan L; Huang H; Zhang Y; Yuan X; Yan Z; Cao C; Luo X
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32163135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
    Chi Y; Shi L; Lu S; Cui H; Zha W; Shan L; Shen Y
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116969. PubMed ID: 37516391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression.
    Poljak-Blazi M; Jaganjac M; Sabol I; Mihaljevic B; Matovina M; Grce M
    Toxicol In Vitro; 2011 Feb; 25(1):160-6. PubMed ID: 21044880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells.
    Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW
    Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
    Peto M; Tolle-Ersü I; Kreysch HG; Klock G
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental studies of using real-time fluorescence quantitative PCR and RT-PCR to detect E6 and E7 genes of human papillomavirus type 16 in cervical carcinoma cell lines].
    Chen YY; Peng ZL; Liu SL; He B; Hu M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):443-6. PubMed ID: 17593827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.
    Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X
    Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
    J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa].
    Sima N; Wang W; Xu Q; Tian X; Luo AY; Lu YP; Wang SX; Ma D
    Ai Zheng; 2007 Jan; 26(1):26-31. PubMed ID: 17222363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells.
    Saengkrit N; Sanitrum P; Woramongkolchai N; Saesoo S; Pimpha N; Chaleawlert-Umpon S; Tencomnao T; Puttipipatkhachorn S
    Carbohydr Polym; 2012 Oct; 90(3):1323-9. PubMed ID: 22939347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Benzylcinnamide induces apoptosis in HPV16 and HPV18 cervical cancer cells via suppression of E6 and E7 protein expression.
    Xiong Y; Chen L; Luo P
    IUBMB Life; 2015 May; 67(5):374-9. PubMed ID: 25914202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.